F. Le Tinier

Adaptive radiotherapy (up to 74 Gy) or standard radiotherapy (66 Gy) for patients with stage III non-small-cell lung cancer, according to [18F]FDG-PET tumour residual uptake at 42 Gy (RTEP7–IFCT-1402): a multicentre, randomised, controlled phase 2 trial

Pierre Véra, S. Thureau, F. Le Tinier et al. · The Lancet Oncology · 2024 · 28 citations

Adaptive Radiotherapy, Radiation Medicine, Radiation Therapy +12

Intensity-modulated radiation therapy with simultaneous integrated boost for locally advanced breast cancer: a prospective study on toxicity and quality of life

F. Le Tinier, Raoudha Bennadji, A. Jouin et al. · Scientific Reports · 2019 · 26 citations · Full text

Adaptive Radiotherapy, Interim Analysis, Advanced Breast Cancer +13

Correlation between toxicity and dosimetric parameters for adjuvant intensity modulated radiation therapy of breast cancer: a prospective study

B. Bataille, F. Le Tinier, Raoudha Bennadji et al. · Scientific Reports · 2021 · 26 citations · Full text

Interest of Supportive and Barrier Protective Skin Care Products in the Daily Prevention and Treatment of Cutaneous Toxicity During Radiotherapy for Breast Cancer

A. Berger, C.A. Regueiro, Tarek Hijal et al. · Breast Cancer Basic and Clinical Research · 2018 · 25 citations · Full text

Usefulness of Stereotactic Body Radiation Therapy for Treatment of Adrenal Gland Metastases

Cyrielle Scouarnec, Joël Luu, F. Le Tinier et al. · Frontiers in Oncology · 2019 · 24 citations · Full text